Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis

Clinical trial NCT00999609 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00999609
Sponsor: Spark Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Inherited Retinal Dystrophy Due to RPE65 Mutations Leber Congenital Amaurosis

Start date: 2012-10-01
Primary completion: 2015-07-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.